Jacobs Solutions target price cut to $160 from $161
J•Truist Securities cut its target price for Jacobs Solutions to $160 from $161.
Related News
Elevance Health schedules conference call, webcast on third-quarter 2026 results
ELV•
Benitec Biopharma targets mid-2027 start for BB-301 pivotal trial in OPMD dysphagia
BNTC•
vTv Therapeutics completes enrollment in Phase 3 CATT1 cadisegliatin trial in type 1 diabetes
VTVT•
Rani Therapeutics RaniPill platform joins FDA Emerging Technology Program
RANI•
ICE September total average daily volume rises 51% y/y
ICE•